Results 131 to 140 of about 2,622 (185)

Emerging role of Janus kinase inhibitors in ulcerative colitis management. [PDF]

World J Gastrointest Pharmacol Ther
Ahsan MU, Sajid SL, Balach R, Daniyal M, Ain NU, Mudasir M.   +5 more
europepmc   +1 more source

Advanced Medical Therapies for Perianal Fistulizing Crohn's Disease: A Systematic Review of Clinical, Radiological, Surgical, and Composite Outcomes. [PDF]

Pharmaceuticals (Basel)
Jamal F, Segun-Omosehin T, Viggiano T, Khan H, Gonzalez AJ, Thomas G, Elmasry S, Malik TA.   +7 more
europepmc   +1 more source

A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients? [PDF]

Curr Opin Lipidol
Muñoz Ayala K, Festen EAM, Westerterp M.   +2 more
europepmc   +1 more source

Monotherapy Versus Combination Therapy of Janus Kinase Inhibitors With Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) in Rheumatoid Arthritis: Evidence From a Systematic Review of Randomized Controlled Trials. [PDF]

Cureus
Mirghani Idris RG, Mohammed Nogod AA, Mohamedalamin E, Ahmed Elhaj FM, Yousif Musa AW, Mohammed Mansoor ME, Elagab EA.   +6 more
europepmc   +1 more source

Comparative Efficacy of Janus Kinase Inhibitors (JAKis) for Ulcerative Colitis in Japanese Regional Healthcare Facilities: A Real-World Database Study. [PDF]

Cureus
Itoi Y, Hashimoto Y, Masuo T, Masuda T, Marubashi K, Iwamoto A, Sekiguchi M, Takahashi K, Kimura Y, Hachisu Y, Tomaru S, Sato K, Tanaka H, Hosaka H, Kuribayashi S, Takeuchi Y, Uraoka T.   +16 more
europepmc   +1 more source

Janus Kinase and Interleukin-6 Inhibitor-Induced Lipid Modulation and Its Association With Major Adverse Cardiovascular Events in Rheumatoid Arthritis: A Systematic Review of Clinical and Biomarker Evidence. [PDF]

Cureus
Patel RM, Dudley L, Morse M, Mihos CG, Kesselman MM.   +4 more
europepmc   +1 more source

Computational identification of small molecules for increased gene expression by synthetic circuits in mammalian cells. [PDF]

Nat Commun
Pisani M, Calandra F, Rinaldi A, Cella F, Tedeschi F, Boffa I, Vozzi D, Brunetti-Pierri N, Carissimo A, Napolitano F, Siciliano V.   +10 more
europepmc   +1 more source

Application of JAK inhibitors in the treatment of rheumatoid arthritis: a systematic analysis based on clinical trial databases and registries. [PDF]

Front Med (Lausanne)
Cao J, Huang R, Chen Y, Li X, Lou J, Xu L, Gu J, Luo Z, Yao T, Xie J.   +9 more
europepmc   +1 more source

The antitumor mechanism of oclacitinib in canine lymphoma. [PDF]

Sci Rep
Harada M, Inanaga S, Sakurai M, Shibutani S, Sugasawa T, Murayama N, Osumi T, Baba Y, Sakai H, Maeda S, Igase M, Mizuno T.   +11 more
europepmc   +1 more source

Effects of Janus Kinase Inhibitors on Rheumatoid Arthritis Pain: Clinical Evidence and Mechanistic Pathways. [PDF]

Biomedicines
Belančić A, Sener S, Sener YZ, Fajkić A, Vučković M, Markotić A, Benić MS, Potočnjak I, Pavlović MR, Radić J, Radić M.   +10 more
europepmc   +1 more source